Regenerative medicine firm hires its first CMO


Harvard Apparatus Regenerative Technology (HART -1.1%) hires Saverio La Francesca, M.D. as Chief Medical Officer.

Dr. Francesca joins the firm from the DeBakey Heart and Vascular Center in Houston. Prior to that he was an attending surgeon at the Department of Cardiopulmonary Transplantation at the Texas Heart Institute. He has direct experience in more than 1,000 organ transplants including 200+ heart and lung transplant procedures.

HART's lead product is a bioreactor/synthetic scaffold system for trachea transplants. Limited Phase 1 clinical trials have begun in Sweden and Russia.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs